ID: ALA5280124

Chembl Id: CHEMBL5280124

Max Phase: Preclinical

Molecular Formula: C69H86ClFN6O21

Molecular Weight: 1389.92

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](OCCC(=O)NCCCC[C@H](NC(=O)CC[C@@H](NC(=O)[C@H](C)NC(=O)/C=C/c4ccc(F)cc4Cl)C(N)=O)C(=O)O)[C@@H](NC(=O)OC(C)(C)C)c4ccccc4)C[C@@](O)([C@@H](OC(=O)c4ccccc4)[C@H]21)C3(C)C

Standard InChI:  InChI=1S/C69H86ClFN6O21/c1-36-46(34-69(92)58(96-62(89)41-20-14-11-15-21-41)56-67(9,57(84)54(83)52(36)66(69,7)8)47(79)33-48-68(56,35-94-48)97-38(3)78)95-63(90)55(53(40-18-12-10-13-19-40)77-64(91)98-65(4,5)6)93-31-29-49(80)73-30-17-16-22-45(61(87)88)75-51(82)28-26-44(59(72)85)76-60(86)37(2)74-50(81)27-24-39-23-25-42(71)32-43(39)70/h10-15,18-21,23-25,27,32,37,44-48,53-56,58,79,83,92H,16-17,22,26,28-31,33-35H2,1-9H3,(H2,72,85)(H,73,80)(H,74,81)(H,75,82)(H,76,86)(H,77,91)(H,87,88)/b27-24+/t37-,44+,45-,46-,47-,48+,53-,54+,55+,56-,58-,67+,68-,69+/m0/s1

Standard InChI Key:  BQJQHHXUJDRCSN-HBSVTOSBSA-N

Alternative Forms

  1. Parent:

    ALA5280124

    ---

Associated Targets(Human)

NOD1 Tchem Nucleotide-binding oligomerization domain-containing protein 1 (1322 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
THP-1 (11052 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NOD2 Tclin Nucleotide-binding oligomerization domain-containing protein 2 (1613 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Peritoneal macrophage (1554 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Nod1 Nucleotide-binding oligomerization domain-containing protein 1 (12 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 1389.92Molecular Weight (Monoisotopic): 1388.5519AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Wen X, Zheng P, Ma Y, Ou Y, Huang W, Li S, Liu S, Zhang X, Wang Z, Zhang Q, Cheng W, Lin R, Li H, Cai Y, Hu C, Wu N, Wan L, Pan T, Rao J, Bei X, Wu W, Jin J, Yan J, Liu G..  (2018)  Salutaxel, a Conjugate of Docetaxel and a Muramyl Dipeptide (MDP) Analogue, Acts as Multifunctional Prodrug That Inhibits Tumor Growth and Metastasis.,  61  (4): [PMID:29357251] [10.1021/acs.jmedchem.7b01407]

Source